Apply online
Complete a confidential eligibility questionnaire (5–10 minutes).
Recruitment complete
Researchers at Clinical Research Australia are investigating whether a probiotic supplement can improve quality of life during perimenopause.
Recruitment for this study is now complete. We are no longer accepting applications. Thank you to everyone who expressed interest.
Interested in future studies?Perimenopause can feel different for everyone
These are among the symptoms investigated in this study.
About the research
Preliminary research suggests probiotics may help with symptoms experienced during the menopausal transition. This study will investigate whether a probiotic called LactoSpore® can improve menopause-related quality of life, including mood, sleep, energy, concentration, vasomotor symptoms, libido, digestion, joint comfort and overall wellbeing.
Blood markers that may be associated with perimenopausal symptoms will also be measured. This is an ethics-approved, randomised, double-blind, placebo-controlled clinical trial. Half of participants will receive LactoSpore® and half will receive placebo capsules.
What participation involves
Complete a confidential eligibility questionnaire (5–10 minutes).
A researcher will discuss the study and assess your eligibility (about 10 minutes).
Attend two assessment visits—at baseline and week 12 (about 30 minutes each).
Samples are collected at a Western Diagnostics Pathology clinic at baseline and week 12.
Take one probiotic or placebo capsule daily for 12 weeks.
Complete brief questionnaires online at weeks 4 and 8 (about 10 minutes).
Study population
Recruitment update
We are no longer accepting applications. Thank you to everyone who expressed interest. You can explore our current studies or join the participant community below to hear about future opportunities.
Questions? Call our research team on 08 9448 7376Future study opportunities
Join our participant community and receive occasional emails when new clinical trials begin recruiting.
No obligation to participate. Unsubscribe at any time.
This optional mailing list is separate from study screening. Please do not provide health information. Privacy policy